Status:
UNKNOWN
Misoprostol Before and After Cesarean Section
Lead Sponsor:
sarah mohamed hassan
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
20-35 years
Phase:
PHASE3
Brief Summary
comparison of the effect of misoprostol before and after cesarean on the blood loss
Detailed Description
70 women who received 600 mg misoprostol rectally preoperatively versus 70 women who received 600 mg misoprostol postoperatively at operating theatre
Eligibility Criteria
Inclusion
- Women not in active labor have reactive non-stress test.
- No contraindications to prostaglandins.
- Have no history of coagulopathy.
Exclusion
- Placenta previa.
- Maternal hypertension.
- Diabetes mellitus.
- Previous CS and those with active labor.
- Multiple Fibroid uterus.
- Multiple pregnancies or polyhydramnios.
- Previous myomectomy, previous history of PPH.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2018
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03463070
Start Date
March 1 2018
End Date
September 1 2018
Last Update
March 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainiy Hospital
Cairo, Egypt, 11562